Abstract

S100A7 is expressed in many squamous cell carcinomas (SCCs). Our previous study revealed that S100A7 was dramatically induced in several SCC cells and activation of the Hippo pathway significantly promoted S100A7 in epidermoid carcinoma cells. However, whether the Hippo pathway regulates S100A7 expression in SCCs remains largely unknown. Here, we uncover that S100A7 induction by the Hippo-YAP pathway displays different characteristic in cervical and glossopharyngeal SCC. In well differentiated HCC94 cervical cells and FaDu pharyngeal cells, S100A7 is easily induced by both suspension and dense culture, which is accompanied by an increase in YAP phosphorylation and a decrease in nuclear YAP. Strikingly, these correlations of S100A7 and YAP reverse after recovery of cell attachment or relief from dense culture. Further examination finds that S100A7 induction is significantly repressed by nuclear YAP, which is validated by activation or inhibition of the Hippo pathway via loss- and/or gain-of- LATS1 and MST1 function. Subsequently, we prove that TEAD1 is required for YAP transcriptional repression of S100A7. However, S100A7 is hardly induced in poorly differentiated SiHa cervical cells and NCI-H226 pulmonary cells even in suspension or activation of the Hippo pathway. More importantly, cervical and lingual SCC tissues array analyses show that S100A7 expression displays the positive correlation with pYAP-S127 and the negative correlation with nuclear YAP in the majority of well differentiated but not in poorly differentiated tissues. Collectively, our findings demonstrate that the different induction of S100A7 toward activation of the Hippo pathway mainly depends on the degree of cell differentiation in cervical and glossopharyngeal SCC.

Highlights

  • Squamous cell carcinomas (SCCs) are the most common cancer and can be very aggressive and metastatic

  • We further demonstrate that S100A7 induction in HCC94 and FaDu squamous cell carcinomas (SCCs) cells is repressed by YAP/TEAD1 via activation of the Hippo pathway

  • Since the upregulation of S100A7 displayed the positive correlation with the degree of differentiation in clinical SCC tissues;[22] we selected three cervical and pharyngeal SCC cell lines with the different degrees of differentiation in order to investigate the role of YAP in S100A7 induction

Read more

Summary

Introduction

Squamous cell carcinomas (SCCs) are the most common cancer and can be very aggressive and metastatic. MST1/2 phosphorylates the hydrophobic motif of LATS1/2 (LATS-HM) and activates the LATS1/2,[15] which in turn directly phosphorylates YAP (Yes-associated protein) at Serine 127 (YAP-S127).[15,16,17,18,19] The phosphorylation of YAP-S127 is required for its cytoplasmic retention, wherein it can no longer acts as a transcriptional coactivator and not promotes or represses YAP-dependent gene expression via binding with TEAD (TEA domain) as YAP in nucleus.[19] Recent studies demonstrate a requirement for the Hippo-YAP pathway to sense the cues from cell morphology and cell density via actin cytoskeleton reorganization.[20,21]. We further demonstrate that S100A7 induction in HCC94 and FaDu SCC cells is repressed by YAP/TEAD1 via activation of the Hippo pathway. Our findings provide a new insight for understanding the characteristic of S100A7 induction by the HippoYAP pathway in cervical and glossopharyngeal SCC

Materials and Methods
Results
Discussion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call